Gsk (GSK) Ending Cash Balance (2009 - 2026)
Gsk (GSK) reported Ending Cash Balance of $3.88 billion for the quarter ended Sep 30, 2026, down 12.3% from $4.43 billion a year earlier.
Powered by 
Analysis
Gsk (GSK) Ending Cash Balance (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk posted Ending Cash Balance of $4.32 billion, up 1.1% from the prior year.
- Ending Cash Balance has a five-year compound annual growth rate of -9.6% (years ended Dec 2020 to Dec 2025).
- By year, Ending Cash Balance came in at $4.27 billion in the year ended Dec 31, 2024 (+17.3%), $3.64 billion in the year ended Dec 31, 2023 (-11.9%), $4.13 billion in the year ended Dec 31, 2022 (-19.9%) and $5.16 billion in the year ended Dec 31, 2021 (-28.1%).
- The figure for the quarter ended Sep 30, 2026 ranks as the lowest quarterly Ending Cash Balance since the quarter ended Mar 31, 2024.
- Year over year, Ending Cash Balance gained in four of the last six quarters, with growth averaging 8.7%.
- The high point for year-over-year Ending Cash Balance in five years was the quarter ended Mar 31, 2022 (growth of 120.4%); the low point was the quarter ended Mar 31, 2023 (a decline of 75.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | 3.88 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.88 Bn |
| Mar 31, 2026 | 4.53 Bn |
| Dec 31, 2025 | 4.32 Bn |
| Sep 30, 2025 | 4.43 Bn |
| Mar 31, 2025 | 5.78 Bn |
| Dec 31, 2024 | 4.27 Bn |
| Sep 30, 2024 | 4.27 Bn |
| Mar 31, 2024 | 3.52 Bn |
| Dec 31, 2023 | 3.64 Bn |
| Sep 30, 2023 | 3.88 Bn |
| Mar 31, 2023 | 3.58 Bn |
| Dec 31, 2022 | 4.13 Bn |
| Sep 30, 2022 | -22.16 Bn |
| Mar 31, 2022 | 14.41 Bn |
| Dec 31, 2021 | 5.16 Bn |
| Sep 30, 2021 | 4.64 Bn |
| Mar 31, 2021 | 6.54 Bn |
| Dec 31, 2020 | 7.17 Bn |
| Sep 30, 2020 | 5.51 Bn |
| Mar 31, 2020 | 5.90 Bn |
API Access
Gsk Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();